Table 1 Summary of studies on the measurement of Lp(a) in patients with breast cancer after chemotherapy
Year | Author | Population type | Treatment | Conclusion | Ref |
|---|---|---|---|---|---|
1996 | Saarto, T | 59 premenopausal women | Cyclophosphamide, methotrexate, and 5-fluorouracil | Lp(a) was significantly higher | [28] |
2016 | Sharma M | 12 women (aged between 25 and 65) | Doxorubicin, cyclophosphamide, epirubicin,5’-fluorouracil and docetaxel | No significant difference in Lp(a)(P > 0.05) | [20] |
2020 | Qi Lu | 1016 premenopausal and 627postmenopausal women and 93 peri-menopausal women | Anthracycline-based and taxane-based | Lp(a) was significantly higher(P < 0.05) | [30] |
2020 | Fanli Qu | 216 premenopausal and 317 postmenopausal women | Docetaxel, epirubicin and cyclophosphamide | No distinct difference in Lp(a)(P > 0.05) | [31] |